Back to Journals » Therapeutics and Clinical Risk Management » Volume 2 » Issue 1
Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
4,922 | Dovepress* | 4,922+ | 1,419 | 6,341 | |
Totals | 4,922 | 1,419 | 6,341 | ||
*Since 15 March 2006 +Since July 2016 |
View citations on Google Scholar